ScholarIQanswers from OpenAlex & ORCID
Marc P. Bonaca
ResearcherPublications, citations & collaboration network
Marc P. Bonaca is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marc P. Bonaca have?
ScholarIQindexed works
Marc P. Bonaca has 584 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marc P. Bonaca have?
ScholarIQcitation count
Marc P. Bonaca has 30,771 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marc P. Bonaca?
ScholarIQh-index
Marc P. Bonaca has an h-index of 70 in OpenAlex.
What is the i10-index of Marc P. Bonaca?
ScholarIQi10-index
Marc P. Bonaca has an i10-index of 215 in OpenAlex.
What is the ORCID of Marc P. Bonaca?
ScholarIQorcid
The ORCID for Marc P. Bonaca is on the source record.
What is the OpenAlex record for Marc P. Bonaca?
ScholarIQopenalex
The OpenAlex for Marc P. Bonaca is on the source record.
What are the most-cited papers on Marc P. Bonaca?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen, Philippe Gabríel Steg, Robert F. Storey, Eva C. Jensen, Giulia Magnani, Sameer Bansilal, M. Polly Fish, KyungAh Im, Olof Bengtsson, Ton Oude Ophuis, Andrzej Budaj, Pierre Théroux, Mikhail Ruda, Christian Hamm, Shinya Goto, Jindřich Špinar, José Carlos Nicolau, Róbert Gábor Kiss, Sabina A. Murphy, Stephen Wiviott, Peter Held, Eugene Braunwald, Marc S. Sabatine
Rivaroxaban in Peripheral Artery Disease after Revascularization
Marc P. Bonaca, Rupert Bauersachs, Sonia S. Anand, E. Sebastian Debus, Mark R. Nehler, Manesh R. Patel, Fabrizio Fanelli, Warren H. Capell, Lihong Diao, Nicole Jaeger, Connie N. Hess, Ákos F. Pap, John M. Kittelson, Ivan Gudz, Lajos Mátyás, Dainis Krieviņš, Rafael Díaz, Marianne Brodmann, Eva Muehlhofer, Lloyd Haskell, Scott D. Berkowitz, William R. Hiatt
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow, Eugene Braunwald, Marc P. Bonaca, Sebastián F. Ameriso, Anthony J. Dalby, Mary Polly Fish, Keith A.A. Fox, Leslie Lipka, Xuan Liu, José Carlos Nicolau, A.J. Oude Ophuis, Ernesto Paolasso, Benjamin M. Scirica, Jindřich Špinar, Pierre Théroux, Stephen D. Wiviott, John Strony, Sabina A. Murphy